Ambu Financial Statements From 2010 to 2024

AMBFF Stock  USD 19.90  0.00  0.00%   
Ambu A/S financial statements provide useful quarterly and yearly information to potential Ambu AS investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ambu A/S financial statements helps investors assess Ambu A/S's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ambu A/S's valuation are summarized below:
Ambu AS does not presently have any fundamental signals for analysis.
Check Ambu A/S financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ambu A/S's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ambu financial statements analysis is a perfect complement when working with Ambu A/S Valuation or Volatility modules.
  
This module can also supplement various Ambu A/S Technical models . Check out the analysis of Ambu A/S Correlation against competitors.

Ambu AS Company Current Valuation Analysis

Ambu A/S's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Ambu A/S Current Valuation

    
  3.73 B  
Most of Ambu A/S's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ambu AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Ambu AS has a Current Valuation of 3.73 B. This is 74.01% lower than that of the Biotechnology sector and 69.95% lower than that of the Health Care industry. The current valuation for all United States stocks is 77.54% higher than that of the company.

Ambu A/S Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ambu A/S's current stock value. Our valuation model uses many indicators to compare Ambu A/S value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ambu A/S competition to find correlations between indicators driving Ambu A/S's intrinsic value. More Info.
Ambu AS is rated second in return on equity category among its peers. It is rated fourth in return on asset category among its peers reporting about  0.60  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ambu AS is roughly  1.67 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ambu A/S's earnings, one of the primary drivers of an investment's value.

About Ambu A/S Financial Statements

Ambu A/S stakeholders use historical fundamental indicators, such as Ambu A/S's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ambu A/S investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ambu A/S's assets and liabilities are reflected in the revenues and expenses on Ambu A/S's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ambu AS. Please read more on our technical analysis and fundamental analysis pages.
Ambu AS develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. Ambu AS was founded in 1937 and is headquartered in Ballerup, Denmark. AMBU AS is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in Ambu Pink Sheet

Ambu A/S financial ratios help investors to determine whether Ambu Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ambu with respect to the benefits of owning Ambu A/S security.